NCT04078048View on ClinicalTrials.gov

Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

August 11, 2017

Study Completion Date

November 15, 2017

Conditions
Schizophrenia
Interventions
DIETARY_SUPPLEMENT

Antioxidants (Vitamin C, E )

For eight weeks, Vitamin C group was intervened with tablet vitamin c 500 mg once a day ,vitamin E group was intervened with Tablet vitamin E 600 I U twice a day.

Trial Locations (1)

54000

Saima Kouser, Lahore

All Listed Sponsors
lead

University of Health Sciences Lahore

OTHER

NCT04078048 - Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia | Biotech Hunter | Biotech Hunter